🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

via @NYTOpinion nytimes.com/2021/06/26/opi…

21/ Finally, thanks to Dan Erkes @antidanimmunity and Science Immunology for your interest in this work. Working with you has truly been a great experience!

Congrats Jason Luke, MD, FACP Phase 3 KEYNOTE-716 KEYTRUDA, Merck anti-PD-1, met primary endpoint (RFS) adjuvant high-risk stage II melanoma vs placebo. Proud to have contributed The Angeles Clinic @CSCancerCare UPMC Hillman Cancer Center #melanoma

First week with the dog is going really well!

Need this for melanoma!

Can we all agree CDAs should NOT be needed just get a look at the schema and inclusion criteria of a pharma-sponsored trial? Involving a hospital lawyer just to look at basic trial information that should already be publicly available is an enormous waste of resources.

Nobel Prize in Physics Honors Work on Climate Change nytimes.com/2021/10/05/sci…

Fantastic job at first (still virtual) #SWOG #melanoma committee meeting by incoming chair @drsapnapatel—lots of new protocols on horizon with great correlates. Next spring in Seattle!!

Breathtaking #SITC21 so much work done during worst of covid-Kudos Mary Dean, SITC staff, president ⁦Dr. Patrick Hwu⁩ , organizers, prog chair Sharma!

The family medicine residency interview

Nick Tschernia, MD 👻 afterlife allegriana 👻 Congrats to one of the smartest physicians I know- oncology or otherwise

1 of the upsides of being off the road for 18 months was learning how to stay connected without traveling, both with each other & with you. Join us for a free holiday concert, streaming live from our living room to yours. Send us your song requests, as we’re crafting our set list

Thank you for pointing out the insensitive wording “salvage therapy” often used by med oncos—don’t forget too (especially to fellows) that “palliative chemo” is only that if it works, not as a way to assuage insistence of patient and family at end of life

Thank you, #PaulFarmer, for helping grow a community of physicians pursuing serious study of the social sciences and humanities. Thank you for your example, your wit, and for telling me that it didn't matter if my clinical and historical interests didn't line up.

#Melanoma Symposium, free bit.ly/36Gvpn1 Join@EssnerRick@kmargolin@MLAscierto Sat Apr30 Fairmont Santa Monica @vernonsondak@jasonlukemd@alliegrossman Sancy Leachman @drsapnapatel@drtrevanfischer@stevenkolkermd & Drs.RKorn,DHoon,PatrickOtt

The oncologist’s typical clinic day- and then evening x.com/Yoda4ever/stat…

Mail - Margolin, Kim - Outlook outlook.office.com/mail/search/re…

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results | Nature Medicine nature.com/articles/s4159…

Congrats to Bella Glitza, MD, PhD and MDACC colleagues for nivo iv and i.t. in melanoma w/leptomening spread—opening the field for more such creative work!!